Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452

The Statistical Analysis of Failure Time Data.

Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875

Validation of a combined comorbidity index

Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587

International scoring system for evaluating prognosis in myelodysplastic syndromes

Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427

Regression modelling strategies for improved prognostic prediction

Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,804

Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives

Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717

The pre-therapeutic classification of co-morbidity in chronic disease

Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Storb, R. F., Deeg, H. J., Whitehead, J., Appelbaum, F. R., Beatty, P. G., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., Farewell, V. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

McSweeney, P. A., Niederwieser, D. W., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,386

Impact of intensity of conditioning therapy in patients aged 40–60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantation

Al-Khabori, M. K., Elemary, M., Xu, W., Guyatt, G. H., Galal, A., Kuruvilla, J. G., Lipton, J. H., Messner, H. A., & Gupta, V. K. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.164 · Cited by 26

Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms

Lim, S.-N., Lee, J., Lee, J.-H., Kim, D., Kim, S. D., Kang, Y.-A., Lee, Y.-S., & Lee, K. (2013) · Blood Research · doi:10.5045/br.2013.48.3.178 · Cited by 26

Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR

Michelis, F. V., Atenafu, E. G., Gupta, V. K., Kim, D. D., Kuruvilla, J. G., Lambie, A., Lipton, J. H., Loach, D., & Messner, H. A. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.71 · Cited by 26

Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial

Chevallier, P., Labopin, M., Socié, G., Tabrizi, R., Fürst, S., Lioure, B., Guillaume, T., Delaunay, J., de Latour, R. P., Vigouroux, S., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.108563 · Cited by 26

Risk-Adjusted Outcome Measurement in Pediatric Allogeneic Stem Cell Transplantation

Matthes‐Martin, S., Pötschger, U., Bergmann, K., Frommlet, F., Brannath, W., Bauer, P., & Klingebiel, T. E. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.12.487 · Cited by 26

Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma

Graf, S. A., Vaughn, J. E., Chauncey, T. R., Storer, B. E., Gopal, A. K., Holmberg, L., McCune, J. S., Bensinger, W., Maloney, D. G., Press, O. W., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.06.007 · Cited by 26

The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60 years

Wall, S. A., Devine, S. M., & Vasu, S. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.07.002 · Cited by 29

Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation

Patel, S. S., Rybicki, L. A., Corrigan, D., Bolwell, B. J., Dean, R. M., Liu, H. D., Gerds, A. T., Hanna, R., Hill, B. T., Jagadeesh, D., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.01.016 · Cited by 26

Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning

Duque‐Afonso, J., Ihorst, G., Waterhouse, M., Zeiser, R., Wäsch, R., Bertz, H., Müller–Quernheim, J., Finke, J., Marks, R., & Prasse, A. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.06.024 · Cited by 26

Hemorrhagic Cystitis after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Protective Effect of MESNA Continuous Infusion

Arango, M., & Arango, D. C. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.04.028 · Cited by 26

Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid Leukemia

Bornhäuser, M., Illmer, T., Oelschlaegel, U., Schetelig, J., Ordemann, R., Schaich, M. A., Hänel, M., Schuler, U. S., Thiede, C., Kiani, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0894 · Cited by 26

Intermittent Zoledronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation

Hari, P., DeFor, T. E., Vesole, D. H., Bredeson, C., & Burns, L. J. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.06.015 · Cited by 26

Treatment of acute myeloid leukemia in older patients

Roboz, G. J. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.3.285 · Cited by 26

EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome

Hernani, R., Aiko, M., Victorio, R., Benzaquen, A. O., Pérez, A., Piñana, J. L., Hernández‐Boluda, J. C., Amat, P., Pastor‐Galán, I., Remigia, M. J., et al. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.04.014 · Cited by 25

Challenges for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors

Oyekunle, A. A., Klyuchnikov, E., Ocheni, S., Kröger, N. M., Zander, A. R., Baccarani, M., & Bacher, U. (2011) · Acta Haematologica · doi:10.1159/000323662 · Cited by 25

Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO)

Rasheed, W. K., Ghavamzadeh, A., Hamladji, R., Othman, T. B., Al-Seraihy, A. S., Abdel-Rahman, F., Elhaddad, A., Alabdulaaly, A., Dennison, D., Ibrahim, A., et al. (2013) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2013.04.001 · Cited by 25

Urinary Liver-Type Fatty Acid-Binding Protein Linked with Increased Risk of Acute Kidney Injury after Allogeneic Stem Cell Transplantation

Shingai, N., Morito, T., Najima, Y., Igarashi, A., Kobayashi, T., Doki, N., Kakihana, K., Ohashi, K., & Ando, M. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.08.022 · Cited by 25

Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20‐year cohort

Toze, C. L., Dalal, C. B., Nevill, T. J., Gillan, T. L., Mourad, Y. R. A., Barnett, M. J., Broady, R. C., Forrest, D. L., Hogge, D. E., Nantel, S. H., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09170.x · Cited by 25

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

Mehta, R. S., de Latour, R. P., DeFor, T. E., Robin, M., Lazaryan, A., Xhaard, A., Bejanyan, N., de Fontbrune, F. S., Arora, M., Brunstein, C. G., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.138990 · Cited by 25

Circulating Biomarkers to Identify Responders in Cardiac Cell therapy

Jokerst, J. V., Cauwenberghs, N., Kuznetsova, T., Haddad, F., Sweeney, T. E., Hou, J., Rosenberg‐Hasson, Y., Zhao, E., Schutt, R. C., Bolli, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04801-7 · Cited by 26

Risk‐adapted GVHD prophylaxis with post‐transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations

Moiseev, I., Pirogova, O. V., Alyanski, A. L., Babenko, E. V., Gindina, T., Darskaya, E. I., Slesarchuk, O. A., Bykova, T. A., Chukhlovin, A. B., Pevtcov, D. E., et al. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13030 · Cited by 25

Reduced-Toxicity Myeloablative Conditioning Consisting of Fludarabine/Busulfan/Low-Dose Total Body Irradiation/Granulocyte Colony-Stimulating Factor–Combined Cytarabine in Single Cord Blood Transplantation for Elderly Patients with Nonremission Myeloid Malignancies

Konuma, T., Kato, S., Isobe, M., Mizusawa, M., Oiwa‐Monna, M., Takahashi, S., & Tojo, A. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.12.004 · Cited by 25

Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms

Narayan, R., Benjamin, J. E., Shah, O., Tian, L., Tate, K. M., Armstrong, R. J., Xie, B. J., Lowsky, R., Laport, G. G., Negrin, R. S., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.03.027 · Cited by 25

Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia

Vey, N. (2020) · Therapeutic Advances in Hematology · doi:10.1177/2040620720913010 · Cited by 25

Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia

Kharfan‐Dabaja, M. A., Labopin, M., Brissot, É., Kroger, N., Finke, J., Ciceri, F., Deconinck, É., Blaise, D., Chevallier, P., Gramatzki, M., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17426 · Cited by 25

Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)

López‐Fernández, T., Vadillo, I. S., de la Guía, A. L., & Barbier, K. H. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00850-3 · Cited by 27

Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid Leukemia

Yalniz, F., Saliba, R. M., Greenbaum, U., Ramdial, J., Popat, U., Oran, B., Alousi, A. M., Olson, A. L., Alatrash, G., Marín, D., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.05.007 · Cited by 25

Cardiac complications associated with hematopoietic stem-cell transplantation

Ohmoto, A., & Fuji, S. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01427-2 · Cited by 30

Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation

Schaffrath, J., Diederichs, T., Unverzagt, S., Wass, M., Gläser, U., Weber, T. E., Binder, M., Müller‐Tidow, C., & Müller, L. P. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04736-0 · Cited by 25

EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide

Mariotti, J., Magri, F., Giordano, L., Philippis, C. D., Sarina, B., Mannina, D., Taurino, D., Santoro, A., & Bramanti, S. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01874-5 · Cited by 25

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

Akahoshi, Y., Nakasone, H., Takenaka, K., Yamasaki, S., Nakamura, M., Doki, N., Tanaka, M., Ozawa, Y., Uchida, N., Ara, T., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009376 · Cited by 25

Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation

Short, N. J., Ong, F., Ravandi, F., Nogueras‐González, G. M., Kadia, T. M., Daver, N. G., Dinardo, C. D., Konopleva, M. Y., Borthakur, G. M., Oran, B., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009632 · Cited by 25

Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors

Kanakry, J. A., Gocke, C. D., Bolaños‐Meade, J., Gladstone, D. E., Swinnen, L. J., Blackford, A. L., Fuchs, E. J., Huff, C. A., Borrello, I., Matsui, W. H., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.07.012 · Cited by 25

Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes

Balleari, E., Salvetti, C., Corso, L. D., Filiberti, R., Bacigalupo, A. P., Bellodi, A., Beltrami, G., Bergamaschi, M., Berisso, G., Calzamiglia, T., et al. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.05.007 · Cited by 25

Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma

Zoellner, A., Fritsch, S. M., Prevalšek, D., Engel, N., Hubmann, M., Reibke, R., Rieger, C. T., Hellmuth, J. C., Haas, M., Mumm, F., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.328 · Cited by 25

Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia

Stölzel, F., Platzbecker, U., Mohr, B., Röllig, C., Middeke, J. M., Thiede, C., Füssel, M., Hänel, M., Schaich, M. A., Ehninger, G., et al. (2013) · Leukemia · doi:10.1038/leu.2013.142 · Cited by 25

The clinical role of procalcitonin in hematopoietic SCT

Koya, J., Nannya, Y., Ichikawa, M., & Kurokawa, M. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.18 · Cited by 25

Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care

Orvain, C., Beloncle, F., Hamel, J., Thépot, S., Mercier, M., Kouatchet, A., Farhi, J., François, S., Guardiola, P., Asfar, P., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001143 · Cited by 25

Reduced-intensity conditioning allogeneic hematopoietic-cell transplantation for older patients with acute myeloid leukemia

Goyal, G., Gundabolu, K., Vallabhajosyula, S., Silberstein, P. T., & Bhatt, V. R. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620716643493 · Cited by 25

Management of Relapsed Diffuse Large B-cell Lymphoma

Crump, M. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2016.07.004 · Cited by 25

Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults

Tsai, S. B., Rhodes, J. M., Liu, H., Shore, T. B., Bishop, M. R., Cushing, M. M., Gergis, U. S., Godley, L. A., Kline, J. P., Larson, R. A., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.12.794 · Cited by 25

Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT)

Park, J., Wehrlen, L., Mitchell, S. A., Yang, L., & Bevans, M. F. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4411-y · Cited by 25

HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment

Rimando, J. C., Slade, M., DiPersio, J. F., Westervelt, P., Gao, F., Liu, C., & Romee, R. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018025437 · Cited by 25

Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention

Dutta, D., Aujla, A. S., Knoll, B. M., & Lim, S. H. (2019) · British Journal of Haematology · doi:10.1111/bjh.16273 · Cited by 28

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes

Devillier, R., Bramanti, S., Fürst, S., Sarina, B., Cheikh, J. E., Crocchiolo, R., Granata, A., Chabannon, C., Morabito, L., Harbi, S., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.270 · Cited by 25

Infectious complications in chronic graft‐versus‐host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced‐ and conventional‐intensity conditioning regimens

Yamasaki, S., Heike, Y., Mori, S., Fukuda, T., Maruyama, D., Kato, R., Usui, E., Koido, K., Kim, S., Tanosaki, R., et al. (2008) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00291.x · Cited by 25

Modified Delphi panel consensus recommendations for management of severe aplastic anemia

Babushok, D. V., Dezern, A. E., de Castro, C., Rogers, Z. R., Beenhouwer, D. O., Broder, M. S., Fanning, S. R., Gibbs, S. N., Hanna, R., Maciejewski, J. P., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011642 · Cited by 27

Allogeneic transplantation for Hodgkin’s lymphoma

Corradini, P., Sarina, B., & Farina, L. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08492.x · Cited by 24

Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma

Bhatt, V. R., & Vose, J. M. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.08.015 · Cited by 24

A modified comorbidity index for hematopoietic cell transplantation

DeFor, T. E., Majhail, N. S., Weisdorf, D. J., Brunstein, C. G., McAvoy, S., Arora, M., & Lé, C. T. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.275 · Cited by 24

Spanning the canyon between stem cell transplantation and palliative care

Roeland, E. J., & Ku, G. (2015) · Hematology · doi:10.1182/asheducation-2015.1.484 · Cited by 25

Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients

Granata, A., Fürst, S., Bramanti, S., Legrand, F., Sarina, B., Harbi, S., Philippis, C. D., Faucher, C., Chabannon, C., Lemarié, C., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0500-x · Cited by 24

Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years

Sheth, V., Potter, V. T., Gandhi, S., Kulasekararaj, A. G., de Lavallade, H., Muus, P., Pagliuca, A., Rice, C., Mehra, V., Grimaldi, F., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000480 · Cited by 25

Graft Failure in Patients With Hematological Malignancies: A Successful Salvage With a Second Transplantation From a Different Haploidentical Donor

Sun, Y., Wang, Y., Wang, F., Yan, C., Cheng, Y., Chen, Y., Zhang, Y., Han, T., Han, W., Suo, P., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.604085 · Cited by 24

Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML

Niederwieser, C., Morozova, E., Zubarovskaya, L., Zabelina, T., Klyuchnikov, E., Janson, D., Wolschke, C., Christopeit, M., Ayuk, F., Moiseev, I., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01410-x · Cited by 24

Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis

Yoshimura, H., Satake, A., Ishii, Y., Ichikawa, J., Saito, R., Konishi, A., Hotta, M., Nakanishi, T., Fujita, S., Ito, T., et al. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.05.019 · Cited by 24

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

Baron, F., Labopin, M., Tischer, J., Ciceri, F., Raiola, A. M., Blaise, D., Sica, S., Vydra, J., Fanin, R., Díez-Martín, J. L., et al. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01781-9 · Cited by 24

FLAMSA reduced‐intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission

Holtick, U., Shimabukuro‐Vornhagen, A., Chakupurakal, G., Theurich, S., Leitzke, S., Burst, A., Hallek, M. J., von Bergwelt‐Baildon, M., Scheid, C., & Chemnitz, J. M. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12615 · Cited by 24

Clustering of comorbidities is related to age and sex and impacts clinical outcome in myelodysplastic syndromes

Bammer, C., Sperr, W. R., Kemmler, G., Wimazal, F., Nösslinger, T., Schönmetzler, A., Krieger, O., Pfeilstöcker, M., Valent, P., & Stauder, R. (2014) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2014.02.002 · Cited by 24

Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients

Hobbs, G. S., & Perales, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4030488 · Cited by 24

Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach

Lodewyck, T., & Cornelissen, J. J. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.03.008 · Cited by 23

Treating octogenarian and nonagenarian acute myeloid leukemia patients—Predictive prognostic models

Harb, A. J., Tan, W. C. C., Wilding, G. E., Ford, L., Sait, S. N. J., Block, A. W., Barcos, M. P., Wallace, P. K., Wang, E. S., & Wetzler, M. (2009) · Cancer · doi:10.1002/cncr.24285 · Cited by 24

Impact of comorbidities on the treatment of non-Hodgkin’s lymphoma: a systematic review

Terret, C., Albrand, G., Rainfray, M., & Soubeyran, P. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2015.1024650 · Cited by 24

From Biology to Clinical Practice: Aging and Hematopoietic Cell Transplantation

Artz, A. S. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.11.003 · Cited by 24

Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant

Spina, F., Alessandrino, P. E., Milani, R., Bonifazi, F., Bernardi, M., Luksch, R., Fagioli, F., Formica, C., & Farina, L. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.603445 · Cited by 24

Current challenges and novel treatment strategies in double hit lymphomas

Anderson, M. A., Tsui, A. E., Wall, M., Huang, D. C. S., & Roberts, A. W. (2015) · Therapeutic Advances in Hematology · doi:10.1177/2040620715608091 · Cited by 24

Haploidentical Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome

Mo, X., Zhang, X., Xu, L., Wang, Y., Yan, C., Chen, H., Chen, Y., Han, W., Wang, F., Wang, J., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.08.026 · Cited by 24

Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial

Skaarud, K. J., Hjermstad, M. J., Bye, A., Veierød, M. B., Gudmundstuen, A. M., Lundin, K. E. A., Distante, S., Brinch, L., Tjønnfjord, G. E., & Iversen, P. O. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.08.002 · Cited by 24

Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation

Jabbour, J., Manana, B., Zahreddine, A., Saade, C., Charafeddine, M., Bazarbachi, A. A., Blaise, D., & Cheikh, J. E. (2018) · Current Research in Translational Medicine · doi:10.1016/j.retram.2018.12.001 · Cited by 24

Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease

Montoro, J., Ceberio, I., Hilden, P. D., Maloy, M., Barker, J. N., Castro-Malaspina, H. R., Dahi, P. B., Koehne, G., Perales, M., Ponce, D. M., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.10.003 · Cited by 24

HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment

Martens, K. L., da Costa, W. L., Amos, C. I., Davis, C., Kesten, M., Lee, S. J., Zakai, N. A., Garcia, D. A., & Li, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003353 · Cited by 24

Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide

Elmariah, H., Naqvi, S. M. H., Kim, J., Nishihori, T., Mishra, A., Perez, L. E., Faramand, R. G., Lazaryan, A., Liu, H. D., Khimani, F., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01219-8 · Cited by 24

Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis

Stiff, P. J., Mumby, P. B., Miler, L., Rodriguez, T. E., Parthswarthy, M., Kiley, K., Porter, N., Batiste, R., Wojtowitz, S., Lichtenstein, S., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705525 · Cited by 24

Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high‐risk patients

BARONCIANI, D., Rambaldi, A., Iori, A. P., Bartolomeo, P. D., Pilo, F., Pettinau, M., Depau, C., Micò, M. C., Santarone, S., & Angelucci, E. (2008) · American Journal of Hematology · doi:10.1002/ajh.21240 · Cited by 24

Impact of hospital volume on clinical outcomes of endoscopic biliary drainage for acute cholangitis based on the Japanese administrative database associated with the diagnosis procedure combination system

Murata, A., Matsuda, S., Kuwabara, K., Fujino, Y., Kubo, T., Fujimori, K., & Horiguchi, H. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0257-x · Cited by 24

Late‐onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatments

Mo, X., Zhang, X., Xu, L. ‐., Wang, Y., Yan, C. ‐., Chen, H., Chen, Y., Han, W., Wang, F. ‐., Wang, J. ‐., et al. (2016) · Transplant Infectious Disease · doi:10.1111/tid.12553 · Cited by 24

La protéinose alvéolaire pulmonaire

Jouneau, S., Kerjouan, M., Briens, E., Lenormand, J.-P., Meunier, C. M., Letheulle, J., Chiforeanu, D., Lainé-Caroff, C., Desrues, B., & Delaval, P. (2014) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2014.08.009 · Cited by 23

Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead

Pasvolsky, O., Kebriaei, P., Shah, B. D., Jabbour, E. J., & Jain, N. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009462 · Cited by 23

CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma

Pophali, P. A., Fein, J. A., Ahn, K. W., Allbee-Johnson, M., Ahmed, N., Awan, F. T., Farhan, S., Grover, N. S., Hilal, T., Iqbal, M., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013863 · Cited by 23

A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy

Zhang, Y., Deng, Y., Zhai, Y., Li, Y., Li, Y., Li, J., Gu, Y., & Li, S. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01736-9 · Cited by 23

Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults

Gent, D. G., Saif, M. A., Dobson, R., & Wright, D. J. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.06.004 · Cited by 25

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome

Cutler, C. S. (2010) · Hematology · doi:10.1182/asheducation-2010.1.325 · Cited by 23

Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy

Dell’Oglio, P., Tian, Z., Leyh‐Bannurah, S., Trudeau, V., Larcher, A., Moschini, M., Trapani, E. D., Umberto Capitanio, A., Briganti, A., Montorsi, F., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0032 · Cited by 23

Quality of life in caregivers of patients receiving chimeric antigen receptor T‐cell therapy

Barata, A., Hoogland, A. I., Hyland, K. A., Otto, A. K., Kommalapati, A., Jayani, R. V., Irizarry‐Arroyo, N., Collier, A., Rodriguez, Y., Welniak, T. L., et al. (2021) · Psycho-Oncology · doi:10.1002/pon.5674 · Cited by 23

Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma

Lemieux, C., Muffly, L. S., Iberri, D. J., Craig, J. K., Johnston, L., Lowsky, R., Shiraz, P., Rezvani, A. R., Frank, M. J., Weng, W., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01371-1 · Cited by 25

Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital

Borrega, J. G., Heger, J., Koehler, P. A., Holtick, U., Hallek, M. J., Scheid, C., Böll, B., Shimabukuro‐Vornhagen, A., Kochanek, M., & Eichenauer, D. A. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04698-3 · Cited by 23

Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience

Macías-Sánchez, M. D. M., Morata‐Tarifa, C., Cuende, N., Cardesa-Gil, A., Cuesta-Casas, M. Á., Cascón, M. J. P., Pascual, A., Martín-Calvo, C., Jurado, M., Pérez‐Simón, J. A., et al. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac003 · Cited by 23

A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older

Backhaus, D., Brauer, D., Pointner, R., Bischof, L., Vučinić, V., Franke, G., Niederwieser, D. W., Platzbecker, U., Jentzsch, M., & Schwind, S. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01833-0 · Cited by 23

Heart failure after allogeneic hematopoietic stem cell transplantation

Mo, X., Xu, L., Liu, D., Zhang, X., Chen, H., Chen, Y., Han, W., Wang, Y., Wang, F., Wang, J., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.021 · Cited by 23

Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis

Lissandre, S., Bay, J.-O., Cahn, J.-Y. Y., Porcher, R., Cacheux, V., Cabrespine, A., Cornillon, J., Cassinat, B., de Latour, R. P., Socié, G., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.276 · Cited by 23

T Cell–Depleted Partial Matched Unrelated Donor Transplant for Advanced Myeloid Malignancy: KIR Ligand Mismatch and Outcome

Weisdorf, D. J., Cooley, S., Devine, S. M., Fehniger, T. A., DiPersio, J. F., Anasetti, C., Waller, E. K., Porter, D., Farag, S. S., Drobyski, W. R., et al. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.11.024 · Cited by 23

Comorbidity burden in patients with chronic GVHD

Wood, W. A., Chai, X., Weisdorf, D. J., Martin, P. J., Cutler, C. S., Inamoto, Y., Wolff, D., Pavletic, S. Z., Pidala, J., Palmer, J. M., et al. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.70 · Cited by 23

Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic cell transplantation

Solh, M., Zhang, X., Connor, K., Brown, S. L., Solomon, S. R., Morris, L. E., Holland, H. K., & Bashey, A. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.62 · Cited by 23

Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML

Holtick, U., Herling, M., Pflug, N., Chakupurakal, G., Leitzke, S., Wolf, D. G. F., Hallek, M. J., Scheid, C., & Chemnitz, J. M. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2887-4 · Cited by 23

Fever after peripheral blood stem cell infusion in haploidentical transplantation with post-transplant cyclophosphamide

Arango, M., & Combariza, J. F. (2017) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2017.03.001 · Cited by 23

Impact of a Nutritional Risk Index on Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation

Sagou, K., Ozeki, K., Ukai, S., Adachi, Y., Fukushima, N., & Kohno, A. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.07.002 · Cited by 23

Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation

Abid, M. B., Hamadani, M., Szabó, A., Hari, P., Graham, M. B., Frank, M., Collier, W. S., Abedin, S. M., Jerkins, J. H., Pasquini, M. C., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.06.006 · Cited by 23

Risk Factors for Delirium in Patients Undergoing Hematopoietic Stem Cell Transplantation

Weckmann, M. T., Gingrich, R., Mills, J. A., Hook, L., & Beglinger, L. J. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400304 · Cited by 23

Acute Complications of Stem Cell Transplant

Rimkus, C. (2009) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2009.03.007 · Cited by 23

Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia

Nakasone, H., Kako, S., Endô, H., Ito, A., Sato, M., Terasako, K., Okuda, S., Tanaka, Y., Yamazaki, R., Oshima, K., et al. (2009) · Hematology · doi:10.1179/102453309x12473408860262 · Cited by 23

TRANSPLANTATION Hematopoietic cell transplantation (HCT)–specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Sorror, M. L., Maris, M. B., Storb, R. F., Baron, F., S, B. M., Maloney, D. G., & Storer, B. E. (2016)

Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights

Sorror, M. L., Storer, B. E., & Storb, R. F. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.131 · Cited by 9

54: Hematopoietic cell transplantation-comorbidity index (HCT-CI)

Kassar, M., Shell, K., Gregory, S. A., Venugopal, P., Shammo, J. M., & Fung, H. C. H. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.12.057

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Kato, R., Fukuda, T., Usui, E., Yamasaki, S., Maruyama, D., Morita, Y., Kim, S., Mori, S., Tanosaki, R., Tajima, K., et al. (2005) · Blood · doi:10.1182/blood.v106.11.2731.2731 · Cited by 1

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

Sorror, M. L., Logan, B. R., Zhu, X., Rizzo, J. D., Cooke, K. R., McCarthy, P. L., Ho, V. T., Horowitz, M. M., & Pasquini, M. C. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.04.004 · Cited by 222